ReviewNaunyn-Schmiedeberg's archives of pharmacology2026
Duloxetine as a gut-brain axis modulator in irritable bowel syndrome: neuroimmune, microbiota, and pharmacogenomic perspectives.
Mokhtar Rejili et al.PubMed ↗Publisher ↗
No numbers read from the abstract.